(Q55466334)

English

Bevacizumab in recurrent malignant glioma.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

title

Bevacizumab in recurrent malignant glioma. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

1 reference

Lauren E Abrey

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

publication date

1 May 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

published in

Current Neurology and Neuroscience Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

page(s)

233-234

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

exact match

https://scigraph.springernature.com/pub.10.1007/s11910-008-0035-9

0 references

cites work

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18541118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18541118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18541118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18541118

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11910-008-0035-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

Dimensions Publication ID

1020810802

0 references

PubMed publication ID

18541118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18541118

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/18541118

(Q55466334)

Bevacizumab in recurrent malignant glioma.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)